BHIVA guidelines for the management of HIV-2 (2021)

US HIV treatment guidelines updated (June 2021)

NICE guidelines on management of chronic pain: exercise but not opiods

BHIVA guidelines on COVID-19 vaccines and people living with HIV: DRAFT online for comment

EACS guidelines updated (v.10.1) for Glasgow conference

BASHH 2020 PEP guidelines: online for comment

New BHIVA guidelines: B/F/TAF now preferred first-line ART and reduced HIV monitoring in the UK during COVID-19

US HIV Guidelines updated (December 2019)

BHIVA 2019 audit shows early access to ART but U=U and peer support both need to be improved

EACS launch major update to European Treatment Guidelines (November 2019)

NHS England best practice in HIV prescribing and multidisciplinary teams

WHO update PrEP guidelines to include event-based dosing

UK issue joint guidelines on HIV discrimination in tattoo and beauty salons

WHO recommends dolutegravir-based ART regimens for all

IAS–USA update of drug resistance mutations (2019)

BHIVA guidelines for adult TB/HIV coinfection (2018)

UK BHIVA pregnancy guidelines updated (2018)

US adult HIV guidelines updated (Oct 2018)

EACS guidelines – version 9.1 update (2018)

UK PrEP guidelines now online (2018)

Access to viral load testing increased from 14% to 61% over two years in Côte d’Ivoire

WHO recommends dolutegravir widely but women’s access will depend on contraception provision (2018)

FDA guidance for developing paediatric ARVs: online for comment (2018)

A new framework for best HIV care: BHIVA Standards of Care revised and updated (2018)

Key changes to upcoming UK HIV pregnancy guidelines (2018)

BHIVA standards of HIV care (2018): online for comment

UK HIV pregnancy guidelines (2018): online for comment

UK guidelines on TB/HIV co-infection: online for comment to 9 February (2018)

US HIV guidelines updated (October 2017): dropping “HIV-infected”

Updated European guidelines launched at EACS 2017

Sexual and reproductive health: draft UK guidelines online for comment (2017)

UK PrEP guidelines: online for comment (Oct 2017)

US IDSA HIV pain management guidelines (2017)

EACS guidelines: seven translations now online (2017)

Drug-drug interactions and hormone therapy for gender transitioning

New NICE/PHE testing guidelines (2017)

WHO guidelines on HIV self-testing and partner notification (2017)

Factsheets for switching to Rezolsta (darunavir/c) or Evotaz (atazanavir/c)

EACS Guidelines updated (October 2016)

Swedish guidelines updated (November 2016)

US DHHS guidelines updated (July 2016)

Sub-Saharan African countries moving quickly to recommend “Treat All”

BHIVA antiretroviral guidelines updated (2016)

New US guidelines strengthen recommendation for ART irrespective of CD4 count (January 2016)

New European HIV guidelines (October 2015): universal ART, first-line integrase and PrEP

European HIV guidelines updated (October 2015)

New UK guidelines on use of vaccines in HIV positive adults (2015)

IAS-USA update resistance guidelines and mutation tables (2015)

UK BHIVA treatment guidelines for HIV positive adults (2015)

WHO guidelines for when to start ART and use of PrEP (September 2015)

New directions in the 2015 WHO ART guidelines

Rapid implementation of the 2013 WHO ART guidelines

Draft BHIVA treatment guidelines (2015): the most significant changes for a decade

US guidelines shift to integrase-based combinations for first-line treatment (2015): Atripla relegated due to side effects

EACS guidelines (2015): translations in 11 languages now available online

UK updates PEP guidelines (2014): raltegravir replaces PIs and no indication if positive partner has an undetectable viral load

BHIVA pregnancy guidelines: 2014 interim update

US HIV guidelines for management of chronic kidney disease (IDSA, 2014)

WHO guidelines for key populations (July 2014): gay men, people who inject drugs, people in prisons, sex workers, transgender people

EASL update guidelines for hepatitis C (April 2014)

New ARV prescribing guidelines for London (2014)

WHO launch treatment guidelines for hepatitis C (2014)

US adult treatment guidelines updated (May 2014)

US PrEP guidelines (May 2014): emphasis on broad access may miss optimal use by people at highest risk

UK guidelines for HIV-related cancers (2014): published online

Post navigation